Lupus and Pregnancy
DOI:
https://doi.org/10.31053/1853.0605.v64.n4.25447Keywords:
lupus, pregnancyAbstract
.Downloads
References
Donaldson LB. De Alvarez RR. Further ohservations ori lupus erythematosus associated with pregnancy. Am Obstel Gynecol 1962:83: 1461-73.
Ellis FA, Bereston ES. Lupus erythematosus associated with pregnancy and menopause. AMA Arch Dcrm Syphilol 1952,65:170-6.
Khamashl.a MA. Systernic lupus erythematosus ami pregnancy. Best Pract Res Clin Rheumatol 2006:20:685-94.
Cervera R, Font J, Carmona F, Balasch J. Pregnancy outcome in systemic lupus erythematosus : gcod news for the new millennium. Autoimmun Rey 2002:1: 354-9.
Boumpas UF, Austin HA, Vaughan EM et al. Risk for sustained amenorrhea in patients with systemic lupus erythematosus receiving intermittent pulse cyclophosphamide therapy Ann lntern Med 1993; 119: 366-69.
Ruiz-Irastorza G, Khamashta MA. Lupus and pregnancy: Ten qucstions and sorne answers. Lupus 2008;17;416-420.
Clowse MEB, Magder LS, Petri M. The irnpact of increased lupus activity on obstetric outcomes. Arthritis Rheum 2005; 52:514- 521.
Lima F, Khamashta MA, Buchanan NMM et al. A study of sixty pregnancies in patients with antiphospholipid syndrome. Clin ExpRheumatol 1996:14: 131-136.
Ramsey-Golclman R, Kutzer JE, Kuller LH, et al. Pregnancy outcome and anti-anticardiolipin antibody in women with systemic lupus eiyffiematosus. Am J Epidemiol 1993; 138: 1057-1069.
Germain S, Nelson-Piercy C. Lupus nephritis and renal disease in pregnancy. Lupus 2006; 15:148-155.
Branch DW, Khamashta MA. Antiphospholipid syndrome: obstetric diagnosis, management and controversies. Obstet Gyriecol 2003; 101: 1333-1344.
Brucato A, Frassi M, Franceschini F, et al. Risk of congenital complete heart block in newboms ofmotherswith anti- Ro/SSA antibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum 2001:44: 1832-1835
Cuadrado MJ Mendonca LLF, Khamashta MA et al. Maternal and fetal outcome in antiphospholipid syndrome pregnancies with a history of previous cerebral ischemia. Arthritis Rheum 1999; 42: S265.
Bonnin M, Mercier FJ, Sitbon O. et' al. Severe pulmonary hypertension during pregnancy. Mode of delivery and anesthetic management of 15 consecutive cases. Anesthesiology 2005; 102: 1133-1137.
Me Millan E, Martin WL, Waugh J, et al. Management of pregnancy in women with pulmonary hypertension secondary to SLE and antiphospholipid syndrome. Lupus 2002; 11: 392-398.
Ostensen M, Khamashta MA, Lockshin M et al. Anti-inulammatory and immunosuppressive drugs and reproduction. Arthritis Res Ther 2006:8:209-227.
Ostensen M, Lockshin M. Doria A et al. lJpdate on safety during pregnancy of biological agents and sorne inimunosuppressive antirheumatic drugs. Rheumatology 2008:47:28-31.
Clowse MEB, Magder L, Witter F et al. Hydroxycloroquine in lupus pregnancy. Arthritis Rheum 2006:54: 3640-7,
Ruiz-Irastorza G, Ramos-Casals M, Brito-Zeron P, Khamashta MA. Clinical efficacy of antimalarlais in systemic lupus erythematosus: a systematic review. And Rheum Dis Dec 2008(Ahead of print). Buchanan NM, Toubi E, Khamashta MA et al. 1-lydroxicloroquine and lupus pregnancy: review of a series of 36 cases. Ann Rheum Dis 1996:55:486-88.
Costedoat-Chalumeau N, Amoura Z. Duhaut P et al. Safety of hydroxycloroquine in pregnant patients with connective tissue diseases: a study of one hundred thirty-three cases compared with a control group. Arthritis Rheum 2003:48: 3207-11.
Mintz G, Nitz J, Gutierrez G, et al. Prospective study ofpregnancy in systemic lupus erythematosus: results of a multi-disciplinary approach. J Rheumatol 1986;! 3:732-9.
Lockshin MD, Reinitz E, Druzin ML et al. Lupus pregnancy: case-control prospective study demonstrating absence of lupus exacerbation during or after pregnancy. Am J Med 1984;77:893-8.
Urowitz MB, Gladman DD, Farewell VT, et al. Lupus and pregnancy studies. Arthritis Rheum 1.993;36:1392-97.
Petri M, Howard D, Repked. Frequency of lupus fiare in pregnancy: the Hopkins lupus pregnancy center experience. Arthritis Rheum 1991:34: 1538-45.
Ruiz-Irastorza G, Lima F, Alves J, et al. Increased rate of lupus fiare during pregnancy and puerperium. Br J Rheumatol 1996:35:133-8.
Worig KL, Chan F'Y, Lee XP. Outcome of pregnancy in patients with systemic lupus erythematosus. A prospective study. Arch InternMed 1991:151: 269-73.
Tandon A. Ibanez D, Gladman DD et al. The effect of pregnancy on lupus nephritis. Arthritis Rheum 2004:50:3941-6.
Levy RA, Vilela VS, Cataldo MJ et al. Hydroxycloroquine in lupus pregnancy: doubleblind and placebo -controlled study. Lupus .2001:10:401-4.
Cortes-Hernandez J, Ordi-Ros J, Paredes F et al. Clinical predictors of fetal and maternal outcome in systemic lupus erythematosus: a prospective study of 103 pregnancies. Rheumatology 2002; 41: 643-650.
Khainashta MA, Ruiz-Irastorza G, Hughes GRV. Systernic lupus erythematosus fiares during pregnancy. Rheum Dis Clin North Am 1997: 23:15-30.
Petri M. The Hopkins Lupus Pregnancy Center: ten key issues in management. Rheum Dis Clin N Am 2007; 33:27-35.
HayslettJP, Lynn Rl. Effect of pregnancy in patients with lupus nephropathy. Kidney mt 1980; 18:207-220.
Jungers P, Dougados M, Pelissler C et al. Lupus nephropathy and pregnancy. Report of 104 cases in 36 patients. Arch Intern Mcd 19821142:771-776.
Imbasciati E, Surian M, Bottino S et al. Lupus nephropathy and pregnancy. A study of 26 pregnancies in patients with systemic lupus eiyhternatosus and nephritis. Nephron 1984:36:46-51.
Packham DK, Lam SS, Nicholls K et al. Lupus nephritis and pregnartcy. Q J Mcd 1992; 83:315-324.
Julkunem H. Renal lupus in pregnancy. Scand J Rheumatol 1998:27: 80-83.
Huong DT, Wechsler B, Vauther- Brouzes D et al. Prcgnancy and its outcome in systemic lupus erythematosus. Q J Mcd 1994;87: 721-29.
Ovlasu E, E, Hicks J, Cameron ,JS. The outcome of pregnancy in women with lupus nephritis. Lupus 1991;l:19-25.
Moroni G, Quaglini S, Banfi G et al. Pregnancy in lupus nephritis. Am J Kidney Dis 2002:40:713-720.
Imbasciati E, Tincani A, Gregorini G et al. Pregnancy in women with pre-existing lupus nephritis: predictors of fetal and maternal outcome. Nephrol Dial Transplant 2008: 1-7.
Zulman J, Tala N, Hoffman GS et al. Frobiems associated with the management of pregnancies in patients with systemic lupus erythematosus. J Rheumatol 1980:7: 37-49.
Bobrie G, Liote F, Houiller P et al. Pregnancy in lupus nephritis and related disorders. Am J Kidney Dis 1987; 9:339-343.
Carmona F, Font J, Moga 1 et al. Class ¡II-TV proliferative lupus nephritis and pregnancy: a study of 42 cases. Am J Reprod Immunol 2005:53:182..
Moroni G, Ponticelli C. Pregnancy after lupus nephritis. Lupus 2005:14:89-94.
Day Cd, Lipkin GW, Savage COS. Lupus nephritis and pregnancy in the 21 st centurv. Nephrol Dial Transplant 2009; 24: 344-47.
Mime F, Redman C, Waiker J et al. The preeclampsia community guideline (PRECOG): how to screen for and detect onset of precclampsia in the community. Br Mcd J 2005;330: 576-580.
Barton JR, Sibai BM. Precliction and prevention of recurrent preeclampsia. Obstet Gynecol 2008: 112:359-372.
Mackillop LII, Germain Si, Nelson- Piercy C, Hughes GRV. Effects of lupus and antiphospholipid syndrome on pregnancy. Yearh Obstel Gynecol 2002; 10: 105-119.
Askie LM, Duley L, Henderson-Smart DJ el al. PARIS Collaborative Group. Antiplatelet agents for prevention of preeclampsia: A metaanalysis of individual patient data. Lancet 2007; 369: 1791-8.
Love PE, Saritoro SA: Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagularit in SLE and in non-SLE disorders. Ann Intern Med 1990; 112: 682-698.
Miyakis 5, Lockshin MD, Atsumi T, Branch DW, Brey RL, Cervera R et al. International Consensus statement on an update of the clasitication entena for definitive antiphospholipid syndrome. J Thromb Haemost 2006: 4 : 295-306.
Lima F. Buchanan NM, Khamashta MA et al. Obstetric outcome in systcmic lupus erythematosus. Seminars Arhtritis Rheum 1995: 25: 184-192.
Opatrny L, David M, Kahn SR, et al. Association hetween antiphospholipid antibodies and recurrent fetal loss in women without autoimmune disease: a metaanalysis. J Rheumatol 2006; 33: 2214-21.
Derksen RH, Khamashta Ma, Branch DW. Management of the obstetric antiphospholipid syndrome. Arthritis Rheum 2004; 50:1028-1039.
Empson M, Lassere M, Craig J, et al. Prevention of recurrent miscarriages for women with antiphospholipid antibody or lupus anticoagulant. Cochrane Database Syst Rey 2005; 18(2):CD002859.
Petri M, Qazi U. Management of the antiphospholipid syndrome in pregnancy. Rheum Dis Clin N Am 2006:32: 59 1-607.
Ruiz Irastorza G, Khamashta MA. Antiphospholipid Syiidrome in pregnancy. Rheum Dis Clin N Am 2007;33:287-97. CarmonaF, FontJ,AzulayM, etal. RiskFactors associated with fetal losses in treated antiphospholipid syndrome pregnancies: a multivariate análisis. Am J Reprod Immuno1 2001; 46: 274-9..
Ruiz Irastorza G, Khamashta MA, Hughes GRV. Treatment of pregnancy loss in Hughes syndrome: a critical update. Autoimmun Rey 2002: 1:298-304.
Ruiz Irastorza G. Khamashta MA.Management of thrombosis in antiphospholipid syndrome and systemic lupus erythematosus in pregnancy. Am NY Acad Se¡ 2005; 1051: 606-12.
Ruiz Irastorza G, Khamashta MA, Nelson-Piercy C et al. Lupus pregnancy: is hepann a risk factor for osteoporosis? Lupus 2001: 10:597-600.
Risk of congenital complete heart block in newboms ofrnothcrswlth anti-Ro/SSAaritibodies detected by counterimmunoelectrophoresis: a prospective study of 100 women. Arthritis Rheum 2001:44, 1832-35.
Gordon P. Khainashta MA, Rosenthal E et al. Anti-52 kDa Ro, anti-60 kDa Ro and ant! La antibody profiles in neonatal lupus. Journal of Rheumatology 2004:31: 2480-87.
Buyon JP, Hiebert R, Copel J et al. Autoimmune associated congenital heart block: demographics, mortality, morbidity, and recurrence rates obtained from a national neonatal lupus registrv. J Am Col] Cardiology 1998;31: 1658-66.
Saleeb S. Cope¡ J, Fnedman D et al. Comparison of treatrnent with fluorinated glucocorticoids to the national history of autoantibody-associated congenital heart block retrospective rev!ew of the research registiy for neonatal lupus. Arthritis Rheum 1999; 42:2335-45.
Downloads
Published
Issue
Section
License
Copyright (c) 2019 Universidad Nacional de Córdoba
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
The generation of derivative works is allowed as long as it is not done for commercial purposes. The original work may not be used for commercial purposes.